glp 1 glucagon dual receptor agonist Main physiological actions of the GIP and GLP-1 GLP-1-based therapies for type 2

Human and Animal Rights and Informed Consent All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines)

Acknowledgements I would like to thank my former PhD students and post-docs Anne Raben, Anne Flint, Camilla Verdich, Birgitte Sloth, Helle Harder, Anita Belza and Thomas Meinert Larsen for their invaluable contributions to the research described in this article

mSphere 5 (1), e00585-19

This has led to some pharmacists stopping the sale of brand-name drugs altogether

Consent to Participate Not applicable

GIP: an inconsequential incretin or not